HINDU WORLD - ENCYCLOPEDIC SURVEY OF HINDUISM, I-II - WALKER,B

被引：0
作者：
EMBREE, AT [1 ]
机构：
[1] DUKE UNIV,DURHAM,NC
来源：
JOURNAL OF ASIAN HISTORY | 1971年 / 5卷 / 01期
关键词：
D O I：
暂无
中图分类号：
K [历史、地理];
学科分类号：
06 ;
摘要：
引用
收藏
页码：58 / 60
页数：3
相关论文
共 50 条
  • [31] T422E mutation in the α1B Ca channel I-II linker reduces affinity for Gβ1 subunits.
    Cooper, C
    Arnot, M
    Hamid, J
    Zamponi, G
    FASEB JOURNAL, 2000, 14 (04) : A70 - A70
  • [32] Mutational analysis of the I-II loop of α1B reveals the importance of β subunits for the G protein modulation of N-type calcium channels
    Leroy, J
    Richards, M
    Butcher, AJ
    Nieto-Rostro, M
    Pratt, WS
    Davies, T
    Dolphin, AC
    BIOPHYSICAL JOURNAL, 2005, 88 (01) : 271A - 271A
  • [33] Value of surveillance studies for patients (pts) with stage I-II diffuse large B-cell lymphoma (DLBCL) in the rituximab (R) era.
    Hiniker, Susan M.
    Pollom, Erqi L.
    Khodadoust, Michael S.
    Kozak, Margaret M.
    Advani, Ranjana H.
    Hoppe, Richard T.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [34] Phase I-II trial of recombinant interferon alpha-2b with cisplatin and 5-fluorouracil in recurrent and/or metastatic carcinoma of head and neck
    Bensmaine, MEA
    Azli, N
    Domenge, C
    Armand, JP
    Cvitkovic, E
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1996, 19 (03): : 249 - 254
  • [35] Improved Outcomes With Radiation Therapy in Stage I-II Primary Mediastinal B-Cell Lymphoma: A Surveillance, Epidemiology, and End Results Database Analysis
    Jackson, M. W.
    Rusthoven, C. G.
    Rabinovitch, R.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2014, 90 : S68 - S68
  • [36] Clinical Outcomes of Neoadjuvant Immunotherapy in Stage I-II Non-Small Cell Lung Cancer: A Real-World Study and Meta-Analysis
    Zhou, H.
    Zhan, W.
    Cai, C.
    Wu, S.
    Lei, Y.
    Chen, Q.
    JOURNAL OF THORACIC ONCOLOGY, 2024, 19 (10) : S545 - S546
  • [37] Combined Modality Therapy for Stage I-II Diffuse Large B-cell Lymphoma Provides Excellent Local Control and Clinical Outcome in the Rituximab Era
    Lao, L.
    Tsang, R.
    Pintilie, M.
    Skliarenko, J.
    Hodgson, D.
    Sun, A.
    Kukreti, V.
    Kuruvilla, J.
    Crump, M.
    Gospodarowicz, M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S644 - S645
  • [38] Treatment of B-lymphoproliferative disorder by a monoclonal anti-interleukin-6 antibody in twelve patients. A multicenter phase I-II clinical trial
    Haddad, E
    Paczesny, S
    Seigneurin, JM
    Stern, M
    Achkar, A
    Bauwens, M
    Delwail, V
    Debray, D
    Duvoux, C
    Hubert, P
    de Ligny, H
    Wijdenes, J
    Durandy, A
    Fischer, A
    TRANSPLANTATION, 2001, 71 (01) : S4 - S4
  • [39] A single-institution retrospective analysis of outcomes for stage I-II primary mediastinal large B-cell lymphoma treated with immunochemotherapy with or without radiotherapy
    Binkley, Michael S.
    Hiniker, Susan M.
    Wu, Sharon
    Natkunam, Yasodha
    Mittra, Erik S.
    Advani, Ranjana H.
    Hoppe, Richard T.
    LEUKEMIA & LYMPHOMA, 2016, 57 (03) : 604 - 608
  • [40] Combination Chemotherapy With Capecitabine (C), Irinotecan (I) Oxaliplatin (O) and Bevacizumab (B) (XELOXIRIA) as First Line Treatment of Metastatic Colorectal Cancer (MCRC) - Preliminary Results of a Phase I-II Trial
    Bazarbashi, S.
    Aljubran, A.
    Soudy, H.
    Alzahrani, A.
    Darwish, A.
    Eltaigani, A.
    Nabil-Ahmed, M.
    Edesa, W.
    Shoukri, M.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S425 - S425
12345